Abstract
We investigated an individual macular corneal dystrophy (MCD) type II cornea from a 42-year-old woman with markedly reduced antigenic keratan sulphate levels. A characteristic 4.6 Å X-ray reflection was evident, and the mid-stroma contained 30% less sulphur than normal. Close packing of collagen was restricted to the superficial stroma. Abnormally large proteoglycan filaments were noted throughout the extracellular matrix and Descemet's membrane's posterior non-banded zone, but not its anterior banded zone. Small, collagen-associated stromal proteoglycans were susceptible to digestion with chondroitinase ABC, but not keratanase I or N-glycanase. On occasion, collagen fibrils ranged in size from 20 nm to 58 nm, with preferential diameters of 34 nm and 42 nm. Corneal guttae were evident, as were numerous endothelial inclusions, most probably due to intracellular fibrillogranular vacuoles similar to those found in the stroma. The endothelium expressed reduced anti-keratan sulphate labelling.
Similar content being viewed by others
Article PDF
References
Klintworth GK . Disorders of glycosaminoglycans (mucopolysaccharides) and proteoglycans. In: Garner A, Klintworth GK, editors. Pathobiology of ocular disease: a dynamic approach. New York: Marcel Decker, 1994:855–92.
Quantock AJ . An erroneous glycosaminoglycan metabolism leads to corneal opacification in macular corneal dystrophy. Glycosylation Dis 1994;1:143–51.
Klintworth GK . Research into the pathogenesis of macular corneal dystrophy. Trans Ophthalmol Soc UK 1980;100:186–94.
Klintworth GK . Macular corneal dystrophy: a localised disorder of mucopolysaccharide metabolism? Proc Clin Biol Res 1982;82:69–101.
Klintworth GK, Smith CF . Macular corneal dystrophy: studies of sulphated glycosaminoglycans in corneal explant and confluent stromal cell cultures. Am J Pathol 1977;89:167–82.
Klintworth GK, Smith CF . Abnormal product of corneal explants from patients with macular corneal dystrophy. Am J Pathol 1980;101:143–57.
Klintworth GK, Smith CF . Abnormalities of proteoglycans synthesised by corneal organ cultures derived from patients with macular corneal dystrophy. Lab Invest 1983;48:603–12.
Hassell JR, Newsome DA, Krachmer JH, Rodrigues M . Macular corneal dystrophy: failure to synthesise a mature keratan sulphate proteoglycan. Proc Natl Acad Sci USA 1980;77:3705–9.
Hassell JR, Newsome DA, Nakazawa K, Rodrigues M, Krachmer JH . Defective conversion of a glycoprotein precursor to keratan sulphate proteoglycan in macular corneal dystrophy. In: Hacks S, Wang J, editors. Extracellular matrix. New York: Academic Press, 1982:397–406.
Nakazawa K, Hassell JR, Hascall VC, Lohmander S, Newsome DA, Krachmer J . Defective processing of keratan sulphate in macular corneal dystrophy. J Biol Chem 1984;259:13751–7.
Yang CJ, SundarRaj N, Thonar EJ-MA, Klintworth GK . Immunohistochemical evidence of heterogeneity in macular corneal dystrophy. Am J Ophthalmol 1988;106:65–71.
Edward DP, Yue BYJT, Sugar J, Thonar EJ-MA, SundarRaj N, Stock EL, Tso MOM . Heterogeneity in macular corneal dystrophy. Arch Ophthalmol 1988;106:1579–83.
Funderburgh JL, Funderburgh ML, Rodrigues MM, Krachmer JH, Conrad GW . Altered antigenicity of keratan sulphate proteoglycan in selected corneal diseases. Invest Ophthalmol Vis Sci 1990;31:419–28.
Klintworth GK, Vogel FS . Macular corneal dystrophy: an inherited acid mucopolysaccharide storage disease of the corneal fibroblast. Am J Pathol 1964;45:565–86.
Morgan G . Macular dystrophy of the cornea. Br J Ophthalmol 1966;50:57–67.
Teng CC . Macular dystrophy of the cornea. Am J Ophthalmol 1966;62:436–54.
Snip RC, Kenyon KR, Green WR . Macular corneal dystrophy: ultrastructural pathology of corneal endothelium and Descemet's membrane. Invest Ophthalmol 1973;12:88–97.
François J, Hanssens M, Teuchy H, Sebruyns M . Ultrastructural findings in corneal macular dystrophy (Groenouw II type). Ophthalmic Res 1975;7:80–9.
Edward DP, Thonar EJ-MA, Srinivasan M, Yue BYTJ, Tso MOM . Macular dystrophy of the cornea: a systemic disorder of keratan sulphate metabolism. Ophthalmology 1990;97:1194–200.
Meek KM, Quantock AJ, Elliott GF, Ridgway AEA, Tullo AB, Bron AJ, Thonar EJ-MA . Macular corneal dystrophy: the macromolecular structure of the stroma observed using electron microscopy and synchrotron X-ray diffraction. Exp Eye Res 1989;49:941–58.
Quantock AJ, Meek KM, Ridgway AEA, Bron AJ, Thonar EJ-MA . Macular corneal dystrophy: reduction in both corneal thickness and collagen interfibrillar spacing. Curr Eye Res 1990;9:393–8.
Quantock AJ, Meek KM, Thonar EJ-MA, Assil KK . Synchrotron X-ray diffraction in atypical macular corneal dystrophy. Eye 1993;7:779–84.
Capel MS . X12B - a facility for time-resolved X-ray diffraction for biology and macromolecular systems at the NSLS. Sync Rad News 1993;6:22–7.
Thonar EJ-MA, Meyer RF, Dennis RF, Lenz ME, Maldonado B, Hassell JR, et al. Absence of normal keratan sulphate in the blood of patients with macular corneal dystrophy. Am J Ophthalmol 1986;102:561–9.
Chandrasekhar S, Esterman MA, Hoffman HA . Microdetermination of proteoglycans and glycosaminoglycans in the presence of guaninidine hydrochloride. Anal Biochem 1987;161:103–8.
Schwartz DE, Choi Y, Sandeil LJ, Hanson WR . Quantitative analysis of collagen, protein and DNA in fixed, paraffin-embedded and sectioned tissue. Histochem J 1985;17:655–63.
Scott JE, Orford CR, Hughes EW . Proteoglycan-collagen arrangements in developing rat tail tendon. Biochem J 1981;195:573–81.
Klintworth GK, Meyer R, Dennis R, Hewitt AT, Stock EL, Lenz ME, et al. Macular corneal dystrophy: lack of keratan sulphate in the serum and cornea. Ophthalmic Paediatr Genet 1986;7:139–43.
Thonar EJ-MA, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, et al. Quantification of keratan sulphate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367–76.
Quantock AJ, Meek KM, Thonar EJ-MA . Analysis of high-angle synchrotron X-ray diffraction patterns obtained from macular dystrophy corneas. Cornea 1992;11:185–90.
Quantock AJ, Klintworth GK, Schanzlin DJ, Capel MS, Lenz ME, Thonar EJ-MA . Proteoglycans contain a 4.6 A repeat in macular dystrophy corneas: X-ray diffraction evidence. Biophys J 1996;70:1966–72.
Fullwood NJ, Tuft SJ, Malik NS, Meek KM, Ridgway AEA, Harrison RJ . Synchrotron X-ray diffraction studies of keratoconus corneal stroma. Invest Ophthalmol Vis Sci 1992;33:1734–41.
Meek KM, Leonard DW . Ultrastructure of the corneal stroma: a comparative study. Biophys J 1993;64:273–80.
Quantock AJ, Meek KM, Fullwood NJ, Zabel RW . Scheie's syndrome: the architecture of corneal collagen and distribution of corneal proteoglycans. Can J Ophthalmol 1993;28:266–72.
Rawe IM, Meek KM, Leonard DW, Takahashi T, Cintron C . Structure of corneal scar tissue: an X-ray diffraction study. Biophys J 1994;67:1743–8.
Hassell JR, Cintron C, Kublin C, Newsome DA . Proteoglycan changes during restoration of transparency in corneal scars. Arch Biochem Biophys 1983;222:362–9.
Ehlers N, Bramsen T . Central thickess in corneal disorders. Acta Ophthalmol (Copenh) 1978;56:412–6.
Donnenfeld ED, Cohen EJ, Ingraham HJ, Poleski SA, Goldsmith E, Laibson PR . Corneal thinning in macular corneal dystrophy. Am J Ophthalmol 1986;101:112–3.
Quantock AJ, Meek KM . Proteoglycan distribution in the corneas of individuals with bullous keratopathy. Biochem Soc Trans 1990;18:958.
Scott JE, Haigh M . Small proteoglycan collagen interactions. Keratan sulphate proteoglycan associates with rabbit corneal collagen fibrils at the ‘a’ and ‘c’ bands. Biosci Rep 1985;5:765–74.
Huang Y, Bron AJ, Meek KM, Vellodi A, McDonald B . Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. Exp Eye Res 1996;62:377–87.
Fullwood NJ, Meek KM . Synchrotron X-ray studies of changes occurring in the corneal stroma during processing for electron microscopy. J Microsc 1993;169:53–60.
Parry DA, Craig AS . Electron microscope evidence for an 80 Å unit in collagen fibrils. Nature 1979;282:213–5.
Vogel KG, Trotter JA . The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Rel Res 1987;7:105–14.
Rada JA, Cornuet PK, Hassell JR . Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core protein. Exp Eye Res 1993;56:635–48.
Klintworth GK, McCracken JS . Corneal diseases. In: Johannessen JV, editor. Electron microscopy in human medicine. New York: McGraw-Hill, 1979:237–66.
Fullwood NJ, Davies Y, Nieduszynski IA, Marcyniuk B, Ridgway AEA, Quantock AJ . Cell-surface-associated keratan sulphate on normal and migrating corneal endothelium. Invest Ophthalmol Vis Sci 1996;37:1256–70.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quantock, A., Fullwood, N., Thonar, EM. et al. Macular corneal dystrophy type II: Multiple studies on a cornea with low levels of sulphated keratan sulphate. Eye 11, 57–67 (1997). https://doi.org/10.1038/eye.1997.12
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.12
Keywords
This article is cited by
-
Structural and biochemical aspects of keratan sulphate in the cornea
Cellular and Molecular Life Sciences (2010)